Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
05/2009
05/05/2009US7527718 Method of treating gas sensor element
05/05/2009US7527716 Connector configuration for electrochemical cells and meters for use in combination therewith
05/05/2009US7527692 Processing apparatus which performs predetermined processing while supplying a processing liquid to a substrate
05/05/2009US7526970 Millimetre-wave detection device for discriminating between different materials
05/05/2009US7526969 Method and device for the contactless detection of flat objects
05/05/2009US7526942 Contact combustion gas sensor
05/05/2009CA2610100A1 Methods and compositions for treating and preventing malaria
05/05/2009CA2606624A1 Methods and compositions for treating and preventing malaria (2)
05/05/2009CA2513549C Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
05/05/2009CA2339006C Method and apparatus for determining anticoagulant therapy factors
05/05/2009CA2318191C Method and apparatus for detecting molecular binding events
05/05/2009CA2315186C Methods for the recovery and measurement of troponin complexes
05/05/2009CA2289942C Determination of cyclin-dependent kinase inhibitor p27 levels as a prognostic factor in cancer patients
05/05/2009CA2274116C Use, of an inhibitor of thioredoxin, for inhibiting tumor growth
05/05/2009CA2249638C Kit and method for fluorescence based detection assay
05/05/2009CA2248247C Means for the biological purification of a biological fluid
05/05/2009CA2234980C Cyclopeptide derivatives
05/05/2009CA2149298C Flk-1 is a receptor for vascular endothelial growth factor
05/01/2009CA2606828A1 Methods of assessing and treating pulmonary disease
04/2009
04/30/2009WO2009055820A2 Salivary protein biomarkers for human oral cancer
04/30/2009WO2009055736A1 Systems and methods for processing sensor data
04/30/2009WO2009055682A1 Crystal structure of the carboxyl transferase domain of human acetyl-coa carboxylase 2 protein (acc2 ct) and uses thereof
04/30/2009WO2009055672A1 System and method of analyzing fluids at a drilling location
04/30/2009WO2009055644A2 Agonists and antagonists of guanylate cyclase receptors of the grueneberg ganglion for use in modulating animal behaviour
04/30/2009WO2009055643A2 Test strip ejection mechanism
04/30/2009WO2009055605A1 Tissue container for molecular and histology diagnostics incorporating a breakable membrane
04/30/2009WO2009055587A1 Microcoil magnetic resonance detectors
04/30/2009WO2009055559A1 Method of predicting chemotherapeutic responsiveness of cancer
04/30/2009WO2009055487A1 Biomarkers for prenatal diagnosis of congenital cytomegalovirus
04/30/2009WO2009055427A2 Methods for evaluating the aggregation of a protein in a suspension including organopolysiloxane and medical articles coated with organopolysiloxane containing a protein solution
04/30/2009WO2009055417A1 Compositions for detecting antibodies to babesia microti and methods of uses thereof
04/30/2009WO2009055382A2 One-step immunoassays exhibiting increased sensitivity and specificity
04/30/2009WO2009055224A1 Monitoring and compensating for temperature-related error in an electrochemical sensor
04/30/2009WO2009055200A2 Downhole spectroscopic hydrogen sulfide detection
04/30/2009WO2009055111A2 Human laminin receptor crystal and uses thereof
04/30/2009WO2009055093A1 Electrochemical methods for selective detection of free chlorine, monochloramine and dichloramine
04/30/2009WO2009055078A2 Identification of the hepcidin binding site on ferroportin
04/30/2009WO2009055063A1 Sensor technique for black liquor oxidation control
04/30/2009WO2009055054A2 Antibody-mediated disruption of quorum sensing in bacteria
04/30/2009WO2009055052A2 Improved methods and devices for cellular analysis
04/30/2009WO2009055010A2 Systems and methods for studying influenza
04/30/2009WO2009054996A2 Systems and methods for viral therapy
04/30/2009WO2009054994A2 Use of compounds activating sirt-3 for mimicking exercise
04/30/2009WO2009054939A2 Cancer classification and methods of use
04/30/2009WO2009054917A1 Methods of selecting epidermal growth factor receptor (egfr) binding agents
04/30/2009WO2009054914A1 Compositions and methods for treatment of diabetic retinopathy
04/30/2009WO2009054814A1 Functionalized poly (3,4-alkylenebridgedthiophene) (pabt)
04/30/2009WO2009054784A1 Method for assessing previous ethanol intake
04/30/2009WO2009054738A1 Monitoring system and method
04/30/2009WO2009054729A1 Immunoassay analysis method
04/30/2009WO2009054718A1 Method for determining the fossil fuel content in a fuel stream, as well as an incineration furnace
04/30/2009WO2009054658A1 Apparatus for measuring concentration of liquid fuel using strain gauge and fuel cell including apparatus
04/30/2009WO2009054617A1 The apparatus for surface treatment of bio-chemical sensor
04/30/2009WO2009054538A1 Method and kit for measurement of acrolein adduct in sample utilizing agglutination reaction of immunological microparticle
04/30/2009WO2009054516A1 Sample detector and measurement device equipped with the same
04/30/2009WO2009054475A1 Method for detection of cancer
04/30/2009WO2009054474A1 Allele judging device and method, and computer program
04/30/2009WO2009054351A1 Biological condition evaluation device, biological condition evaluation method, biological condition evaluation system, biological condition evaluation program, and recording medium
04/30/2009WO2009054350A1 Method for evaluation of impaired glucose tolerance
04/30/2009WO2009054320A1 Nucleic acid probe, and method for production of probe polymer
04/30/2009WO2009054136A1 Cell separation method using magnetic microparticle bound to fused polypeptide
04/30/2009WO2009054128A1 Method for efficient production of monocyte-derived multipotent cell (momc)
04/30/2009WO2009054104A1 Apparatus and method for detecting presence or determining biologically specifically reactive substance
04/30/2009WO2009054091A1 Antibody directed against pro-gastrin releasing peptide, and use thereof
04/30/2009WO2009053987A1 Antibodies specific to pro-angiogenic isoforms of vascular endothelial growth factor (vegf)
04/30/2009WO2009053981A2 Electronic nose device with sensors composed of nanowires of columnar discotic liquid crystals with low sensitivity to humidity
04/30/2009WO2009053958A1 A breath sampling system
04/30/2009WO2009053880A1 Device and method for the monitoring of the movement of cells
04/30/2009WO2009053875A2 Barrier layer over electrodes of electrically active loc devices
04/30/2009WO2009053870A2 Device and method for the monitoring of the movement of cells
04/30/2009WO2009053844A1 Synthetic antigenic peptides and lipopeptides derived fro mycobacterium avium subsp. paratuberculosis
04/30/2009WO2009053841A2 Test device for platelet aggregation detection.
04/30/2009WO2009053834A1 Apparatus and method for electrochemical detection
04/30/2009WO2009053761A1 Container for calibration gas
04/30/2009WO2009053683A2 Treatment of inflammatory diseases
04/30/2009WO2009053637A2 Anti-ricin antibody
04/30/2009WO2009053604A2 Influenza virus haemagglutinin-specific monoclonal antibodies
04/30/2009WO2009053602A2 Automated cell density adjustment method for producing an analysis plate
04/30/2009WO2009053597A2 Novel method for preparing nanoparticles covered with an organic stabilising layer coupled to targeting ligands
04/30/2009WO2009053596A2 Novel method for preparing nanoparticles covered with a gem-bisphosphonate stabilising layer coupled to hydrophilic biodistribution ligands
04/30/2009WO2009053568A1 Method for estimating the concentration of a component of a fluid contained in a tank after an adjunction of fluid in said tank
04/30/2009WO2009053537A1 Methods and products for diagnosing autoimmune diseases and gastric cancer linked with atrophic gastritis
04/30/2009WO2009053523A1 A new biomarker for monitoring development of diseases and assessing the efficacy of therapies
04/30/2009WO2009053514A1 Method for the diagnosis and treatment of diseases which develop with alteration of kinase p38, elements necessary therefor and applications thereof
04/30/2009WO2009053512A1 Porcine torovirus proteins n, m and he, method for production thereof and uses thereof in diagnosis and treatment of porcine torovirus
04/30/2009WO2009053508A1 Method for the detection and quantification of yeast of the genera brettanomyces and/or dekkera in red wine and other fermented or carbonated drinks
04/30/2009WO2009053465A1 Ppm1e proteins and nucleic acids as targets for neurodegenerative diseases
04/30/2009WO2009053393A1 A method for measuring the biological diversity of a sample
04/30/2009WO2009053354A1 Use of tenascin-w as a biomarker for colon cancer
04/30/2009WO2009053195A1 Method and system for detection of a selected type of molecules in a sample.
04/30/2009WO2009053020A1 Method and apparatus for analysis of force traces
04/30/2009WO2009052972A2 Use of norgestimate as a selective inhibitor of trpc3, trpc6 and trpc7 ion channels
04/30/2009WO2009052837A2 Maldi ms-based high-throughput screening method for substances inhibiting aggregation of alzheimer's amyloid beta peptides
04/30/2009WO2009052628A1 Antibodies against a cancer-associated epitope of variant hnrnpg and uses thereof
04/30/2009WO2009052623A1 Therapeutic and diagnostic methods using tim-3
04/30/2009WO2009052557A1 Methods of prognosis
04/30/2009WO2009036283A9 Differential diagnosis of b-cell chronic lymphocytic leukemia
04/30/2009WO2009036168A3 Devices and methods for the collection and detection of substances
04/30/2009WO2009034563A3 An analysis system
04/30/2009WO2009033670A3 Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection